自動細胞イメージングシステム市場規模、シェア、成長分析：製品・サービス別、用途別、技術別、エンドユーザー別、地域別 - 産業予測 2025～2032年

自動細胞イメージングシステム2023年の市場規模は1,274億8,000万米ドルで、2024年の1,379億3,000万米ドルから2032年には2,591億1,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは8.2％で成長する見通しです。

自動細胞イメージングシステム市場は、世界の慢性疾患有病率の上昇と医薬品・ワクチン研究開発への投資増に後押しされ、力強い成長が見込まれています。しかし、メンテナンスコストの高さやスペアパーツの入手制限といった課題が、市場拡大の妨げになる可能性があります。北米は現在、先進ヘルスケア技術の早期導入により市場を独占しており、この分野では米国がリードしています。一方、アジア太平洋地域は、ヘルスケアインフラへの多額の投資を背景に急成長を遂げています。全体として、成長機会は有望であるが、自動細胞イメージングシステム市場の勢いを持続させるには、既存の課題に対処することが重要です。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ
• 規制情勢

自動細胞イメージングシステム市場規模：製品・サービス別& CAGR（2025-2032）

• 市場概要
• 機器
• 消耗品
• ソフトウェア
• サービス

自動細胞イメージングシステム市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 創薬
• 診断
• 生物学および生物医学調査
• その他の用途

自動細胞イメージングシステム市場規模：技術別& CAGR（2025-2032）

• 市場概要
• 蛍光イメージング
• 明視野イメージング
• ハイコンテントスクリーニング
• その他の技術

自動細胞イメージングシステム市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 製薬・バイオテクノロジー企業
• 学術調査機関
• 病院
• 診断検査室
• その他のエンドユーザー

自動細胞イメージングシステム市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• General Electric Company（USA）
• Olympus Corporation（Japan）
• PerkinElmer Inc.（USA）
• Sartorius AG（Germany）
• Thermo Fisher Scientific Inc.（USA）
• West Medica（Austria）
• Norma Diagnostika GmbH（Germany）
• BioView Ltd.（Israel）
• Caliber I.D.（USA）
• Molecular Devices, LLC（USA）
• Nikon Corporation（Japan）
• Leica Microsystems GmbH（Germany）
• Carl Zeiss AG（Germany）
• Agilent Technologies, Inc.（USA）
• Becton, Dickinson and Company（USA）
• Merck KGaA（Germany）
• Tecan Group Ltd.（Switzerland）
• Danaher Corporation（USA）

結論と提言

Automated Cell Imaging System Market size was valued at USD 127.48 billion in 2023 and is poised to grow from USD 137.93 billion in 2024 to USD 259.11 billion by 2032, growing at a CAGR of 8.2% during the forecast period (2025-2032).

The market for automated cell imaging systems is poised for robust growth, fueled by rising chronic disease prevalence globally and increased investment in drug and vaccine research and development. However, challenges such as high maintenance costs and limited spare parts availability may hinder market expansion. North America currently dominates the market, driven by early adoption of advanced healthcare technologies, with the USA leading in this sector. Meanwhile, the Asia-Pacific region is experiencing rapid growth, attributed to significant investments in healthcare infrastructure. Overall, while opportunities for growth are promising, addressing the existing challenges will be crucial to sustaining momentum in the automated cell imaging system market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Automated Cell Imaging System market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Automated Cell Imaging System Market Segments Analysis

Global Automated Cell Imaging System Market is segmented by Product, Application, Technology, End User and region. Based on Product, the market is segmented into Instruments, Consumables, Software and Services. Based on Application, the market is segmented into Drug Discovery, Diagnostics, Biological and Biomedical Research and Other Applications. Based on Technology, the market is segmented into Fluorescence Imaging, Brightfield Imaging, High-Content Screening and Other Technologies. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals, Diagnostic Laboratories and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Automated Cell Imaging System Market

The Automated Cell Imaging System market is significantly driven by the rising incidence of genetic deformities caused by lifestyle changes and radiation exposure, which can lead to irregular cell division and tumor development. Additionally, contamination of water, food, and soil with certain chemicals contributes to cancer prevalence. The emergence of new cancer types necessitates advanced imaging technologies to study the dynamics and functions of telomeric repeat-containing RNA, underscoring the importance of automated cell imaging systems. These systems have become essential tools in cellular research, enabling scientists to analyze digital microscopic images of cancerous cells with precision and efficiency, thereby propelling market growth.

Restraints in the Automated Cell Imaging System Market

The Automated Cell Imaging System market faces significant restraints due to the high costs associated with both spare parts and initial setup. When components of these systems become damaged, they often need to be fully replaced, leading to substantial expenses, exacerbated by the limited number of manufacturers available, which creates a supply deficit. Additionally, the initial investment necessary to establish such systems can be quite steep, coupled with the requirement for considerable electricity to operate them. These factors combined present notable challenges for market growth and limit accessibility for many potential users.

Market Trends of the Automated Cell Imaging System Market

The Automated Cell Imaging System market is witnessing significant growth driven by a surge in research and development of new drugs, as major pharmaceutical companies increasingly invest in advanced technologies. This trend is fueled by the need for high-throughput screening and precise analysis in drug discovery, as these systems minimize human error and reduce the time required for interventions in lengthy experiments involving extensive chemical libraries. By acquiring and analyzing high-resolution images, automated cell imaging systems enhance the efficiency and accuracy of research processes, thereby accelerating the development of innovative vaccines and therapeutics and positioning themselves as indispensable tools in modern biomedical research.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape

Global Automated Cell Imaging System Market Size by Product & Service & CAGR (2025-2032)

• Market Overview
• Instruments
• Consumables
• Software
• Services

Global Automated Cell Imaging System Market Size by Application & CAGR (2025-2032)

• Market Overview
• Drug Discovery
• Diagnostics
• Biological and Biomedical Research
• Other Applications

Global Automated Cell Imaging System Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Fluorescence Imaging
• Brightfield Imaging
• High-Content Screening
• Other Technologies

Global Automated Cell Imaging System Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Hospitals
• Diagnostic Laboratories
• Other End Users

Global Automated Cell Imaging System Market Size & CAGR (2025-2032)

• North America (Product & Service, Application, Technology, End User)
  • US
  • Canada
• Europe (Product & Service, Application, Technology, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Service, Application, Technology, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Service, Application, Technology, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Service, Application, Technology, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• General Electric Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• West Medica (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Norma Diagnostika GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioView Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Caliber I.D. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Molecular Devices, LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nikon Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Leica Microsystems GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Carl Zeiss AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tecan Group Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations